PRAX
Praxis Precision Medicines IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$6.91B
P/E Ratio
—
EPS
$-13.39
Beta
2.75
52W High
$366.52
52W Low
$37.19
50-Day MA
$320.55
200-Day MA
$239.76
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Praxis Precision Medicines Inc
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. The company is headquartered in Cambridge, Massachusetts.
Fundamentals
| Revenue (TTM) | $7.46M |
| Gross Profit (TTM) | $-284.30M |
| EBITDA | $-357.20M |
| Operating Margin | 0.00% |
| Return on Equity | -35.30% |
| Return on Assets | -23.00% |
| Revenue/Share (TTM) | $0.35 |
| Book Value | $50.61 |
| Price-to-Book | 4.90 |
| Price-to-Sales (TTM) | 953.14 |
| EV/Revenue | 1215.61 |
| EV/EBITDA | -6.86 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 1349.00% |
| Shares Outstanding | $27.88M |
| Float | $24.02M |
| % Insiders | 0.32% |
| % Institutions | 116.75% |
Historical Volatility
HV 10-Day
150.65%
HV 20-Day
112.23%
HV 30-Day
93.75%
HV 60-Day
82.12%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($627.59 target)
2
Strong Buy13
Buy1
Hold1
SellMore HEALTHCARE Stocks
Data last updated: 6/13/2026